- THIS ARTICLE
- Full Text
- Full Text (PDF)
-
All Versions of this Article:
genetics.107.070946v1
175/4/1695 most recent - Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Miyatake, M.
- Articles by Sugiura, R.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Miyatake, M.
- Articles by Sugiura, R.
Originally published as Genetics Published Articles Ahead of Print on February 7, 2007.
Genetics, Vol. 175, 1695-1705, April 2007, Copyright © 2007
doi:10.1534/genetics.107.070946
Valproic Acid Affects Membrane Trafficking and Cell-Wall Integrity in Fission Yeast
Makoto Miyatake*,
Takayoshi Kuno*,
Ayako Kita
,
Kosaku Katsura
,
Kaoru Takegawa
,
Satoshi Uno*,
Toshiya Nabata* and
Reiko Sugiura
,1
* Division of Molecular Pharmacology and Pharmacogenomics, Department of Genome Sciences, Kobe University Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan,
Laboratory of Molecular Pharmacogenomics, School of Pharmaceutical Sciences, Kinki University, Higashi-Osaka 577-8502, Japan and
Department of Life Sciences, Faculty of Agriculture, Kagawa University, Kagawa 761-0795, Japan
1 Corresponding author: Laboratory of Molecular Pharmacogenomics, School of Pharmaceutical Sciences, Kinki University, Kowakae 3-4-1, Higashi-Osaka, Osaka, 577-8502, Japan.
E-mail: sugiurar{at}phar.kindai.ac.jp
Valproic acid (VPA) is widely used to treat epilepsy and manic-depressive illness. Although VPA has been reported to exert a variety of biochemical effects, the exact mechanisms underlying its therapeutic effects remain elusive. To gain further insights into the molecular mechanisms of VPA action, a genetic screen for fission yeast mutants that show hypersensitivity to VPA was performed. One of the genes that we identified was vps45+, which encodes a member of the Sec1/Munc18 family that is implicated in membrane trafficking. Notably, several mutations affecting membrane trafficking also resulted in hypersensitivity to VPA. These include ypt3+ and ryh1+, both encoding a Rab family protein, and apm1+, encoding the µ1 subunit of the adaptor protein complex AP-1. More importantly, VPA caused vacuolar fragmentation and inhibited the glycosylation and the secretion of acid phosphatase in wild-type cells, suggesting that VPA affects membrane trafficking. Interestingly, the cell-wall-damaging agents such as micafungin or the inhibition of calcineurin dramatically enhanced the sensitivity of wild-type cells to VPA. Consistently, VPA treatment of wild-type cells enhanced their sensitivity to the cell-wall-digesting enzymes. Altogether, our results suggest that VPA affects membrane trafficking, which leads to the enhanced sensitivity to cell-wall damage in fission yeast.